MSD has agreed a deal with Google Cloud that will put the tech giant's AI tools in the hands of its 75,000 employees ...
As proven by the news of Merck and NVidia’s new partnership, for example. But while the idea of using AI for drug discovery ...
The first recipients of funding under the UK government's £500 million Sovereign AI programme have been announced, intended ...
The first volunteers in a large-scale trial of Moderna's mRNA-based vaccine against bird flu – long considered to be a ...
Roche has said its oral BTK inhibitor fenebrutinib could become the first drug in the class to be approved for multiple ...
The FDA has extended its review of a new subcutaneous formulation of Sanofi's multiple myeloma therapy Sarclisa – which has ...
The Trump administration has extended the duration of a pilot programme to provide access to obesity drugs through Medicare, ...
Too many patient access strategies stop at “script filled”. But this approach is ultimately short-sighted, failing to build ...
Roche could be just months away from an FDA approval of Gazyva as the first anti-CD20 therapy for systemic lupus ...
In the pharmaceutical and healthcare sectors, where precision is paramount and human lives are directly impacted, these ...
Novo Nordisk acquired rights to etavopivat when it bought Forma Therapeutics for $1.1 billion in 2022, when the drug was in ...
After years of constrained capital markets, biotech companies are operating in an environment where even late-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results